N
21.60
0.08 (0.37%)
| Penutupan Terdahulu | 21.52 |
| Buka | 21.57 |
| Jumlah Dagangan | 204,255 |
| Purata Dagangan (3B) | 297,500 |
| Modal Pasaran | 680,951,488 |
| Harga / Buku (P/B) | 42.81 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Aug 2026 |
| EPS Cair (TTM) | -1.13 |
| Nisbah Semasa (MRQ) | 3.28 |
| Aliran Tunai Operasi (OCF TTM) | -12.06 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.67 M |
| Pulangan Atas Aset (ROA TTM) | -52.69% |
| Pulangan Atas Ekuiti (ROE TTM) | -115.29% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Nuvectis Pharma, Inc. | Bercampur | Menurun |
AISkor Stockmoo
1.3
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.33 |
|
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 46.91% |
| % Dimiliki oleh Institusi | 9.93% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Iridian Asset Management Llc/Ct | 30 Jun 2026 | 777,078 |
| Occam Crest Management Lp | 31 Mar 2026 | 407,147 |
| Baldwin Wealth Partners Llc/Ma | 30 Jun 2026 | 382,015 |
| Forbes J M & Co Llp | 30 Jun 2026 | 59,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |